OLIG2 and neoplasm: Additionally, we detected the expression of Olig2 and CD133 in tumor tissues using immunohistochemical staining and the results indicated that Olig2 and CD133 protein level was decreased clearly in the ACT001-treated groups versus control group and ADR group (5j).